Sammenlignet med de historiske data for voksne havde de 6 til 11- årige 26% højere AUC( 0- 24), men samme Cmax og Cmin- værdier.
Children 6 to 11 years of age (n=9) receiving fosamprenavir / ritonavir 18 / 3 mg/ kg twice daily had 26% higher AUC(0-24) and similar Cmax and Cmin values when compared to the historical adult population receiving fosamprenavir / ritonavir 700 / 100 mg twice daily.